Medicalgorithmics obtains CE certification for VCAST technology
Medicalgorithmics, a medtech company listed on the sWIG80 index, has completed the CE certification process for its VCAST software, which is used for the non-invasive diagnosis of coronary artery disease. Obtaining the certification allows the company to commercialize the technology in the EU and selected countries outside of Europe. The VCAST software, which uses artificial intelligence algorithms to analyze heart CT scan images, is developed by Kardiolytics Inc., Medicalgorithmics’ U.S. subsidiary. The company estimates that the commercialization of the VCAST technology could generate revenues of PLN 130 million by 2028.